Silynxcom director reports stock option holdings

Silynxcom Ltd. director Efrat Itiel has reported existing derivative holdings in a Form 3.

Rhea-AI Filing Summary

Silynxcom Ltd. director Efrat Itiel has reported existing derivative holdings in a Form 3. The filing shows share options giving the right to buy 26,840 ordinary shares at an exercise price of 4.0000 per share, expiring on January 31, 2029. These options were granted on January 31, 2024 and vest in three equal annual installments starting January 30, 2025 through January 30, 2027. The entry reflects holdings only, with no reported purchases or sales of shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Efrat Itiel

Role Director

Type	Security	Shares	Price	Value
holding	Share options (right to buy)	--	--	--

Holdings After Transaction: Share options (right to buy) — 26,840 contracts (Direct)

Footnotes (1)

1. F1. The options were granted on January 31, 2024, and vest in three equal annual installments, beginning January 30, 2025, until January 30, 2027.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Silynxcom (SYNX) director Efrat Itiel report in this Form 3?

Efrat Itiel reports existing holdings of share options in Silynxcom Ltd. The Form 3 lists options to acquire 26,840 ordinary shares, documenting her derivative position as a director rather than any new share purchase or sale.

How many Silynxcom (SYNX) shares are covered by Efrat Itiel’s options?

The reported share options cover 26,840 underlying ordinary shares of Silynxcom Ltd. This entire amount is tied to a single option grant described in the filing, outlining the scale of her potential equity exposure through these derivatives.

What are the key terms of Efrat Itiel’s Silynxcom (SYNX) share options?

The options carry an exercise price of 4.0000 per share and expire on January 31, 2029. They were granted on January 31, 2024, and relate to ordinary shares with no par value per share as the underlying security.

How do Efrat Itiel’s Silynxcom (SYNX) options vest over time?

The options vest in three equal annual installments. Vesting begins on January 30, 2025 and continues annually until January 30, 2027, meaning one-third of the grant becomes exercisable on each of those dates.

Does this Silynxcom (SYNX) Form 3 show any insider buying or selling?

The Form 3 does not show any insider buying or selling activity. It records a holding entry for share options only, with no reported transactions changing the number of shares or options owned on the reported date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/19/2026 - 06:28 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Efrat Itiel

(Last) (First) (Middle)

7 GIBOREI ISRAEL

(Street)

NETANYA 4250407

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Silynxcom Ltd. [ SYNX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share options (right to buy)(1)	01/30/2025	01/31/2029	Ordinary Shares, no par value per share	26,840	$4	D

Explanation of Responses:

1. The options were granted on January 31, 2024, and vest in three equal annual installments, beginning January 30, 2025, until January 30, 2027.

	/s/ Itiel Efrat	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)